U.S. Markets closed

Merck & Co., Inc. (MRK)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
64.92-0.12 (-0.18%)
At close: 4:02PM EDT

64.92 0.00 (0.00%)
After hours: 4:56PM EDT

People also watch
PFEJNJBMYLLYPG
Interactive chart
Previous Close65.04
Open65.00
Bid0.00 x
Ask0.00 x
Day's Range64.82 - 65.21
52 Week Range55.10 - 66.80
Volume3,685,720
Avg. Volume8,994,761
Market Cap177.57B
Beta0.95
PE Ratio (TTM)41.38
EPS (TTM)1.57
Earnings DateJul 28, 2017
Dividend & Yield1.88 (2.94%)
Ex-Dividend Date2017-03-13
1y Target EstN/A
Trade prices are not sourced from all markets
  • Zacks7 hours ago

    Top Analyst Reports for Visa, GE, GlaxoSmithKline & Others

    Top Analyst Reports for Visa, GE, GlaxoSmithKline & Others

  • American City Business Journals7 hours ago

    ​Cambridge biotech Enumeral faces uncertain future as cash dries up

    Cambridge cancer drug developer Enumeral could be forced to downsize, file for bankruptcy or sell its assets unless it quickly raises additional capital, the company said this week. Amid the cash crunch, Enumeral said it is “exploring a range of potential transactions.” According to the company, that could include a public or private offering, debt financing, collaborations and licensing deals, or a potential merger or asset sale. A representative for Enumeral did not immediately respond to an interview request on Friday.

  • UnitedHealth's (UNH) Business Unit Collaborates with Merck
    Zacks9 hours ago

    UnitedHealth's (UNH) Business Unit Collaborates with Merck

    UnitedHealth Group, Inc.???s (UNH) information and technology-enabled health services business "Optum" recently announced its collaboration with Merck & Co. Inc (MRK).